A recombinant long-acting insulin and hypoglycemic agent in which a MYRISTIC ACID is conjugated to a LYSINE at position B29. It is used to manage BLOOD GLUCOSE levels in patients with DIABETES MELLITUS.
Also Known As:
Levemir; 12C-Lys(B29)-DB30I; B29-tetradecanoyl-Lys-B30-des-Ala-insulin; Basal Insulin Detemir; Des-(B30)-insulin, Lys(B29)-tetradecanoyl; Insulin, Tetradecanoyl-Lys(B29)-des-Ala(B30); Insulin, Tetradecanoyllysyl(B29)-desalanyl(B30); NN 304; NN-304; NN304; B29 tetradecanoyl Lys B30 des Ala insulin; Detemir, Basal Insulin; Detemir, Insulin; Insulin Detemir, Basal